SAMHSA’s GAINS Center for Behavioral Health and Justice Transformation, operated by Policy Research Associates, Inc. (PRA), is known nationally for its work in regard to people with behavioral health needs involved in the criminal justice system. Although prevalence estimates vary, there is consensus that high percentages of justice-involved women and men have experienced serious trauma … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
On July 21st, NCACC is partnering with the North Carolina Department of Health and Human Services to host Working Together to End Stigma: Wake County Drug Overdose Prevention Coalition Meeting. The meeting has both virtual and in person options for participation and will take place from 9:00-12:00 and focus on addressing stigma related to drug … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Perinatal Substance Use Disorders 101 provides a foundational knowledge of substance use disorders in pregnant mothers and provides learners with the tools and information needed to provide safe, evidence-based care. Topics will include epidemiology, screening, and treatments such as medication for opioid use disorder. Emphasis will be placed on barriers to care, harm reduction in … Read more
This is the first in a two-part series focused on the sexual and reproductive health needs of women and others assigned female at birth. We will describe trends for incarceration and criminal legal involvement during pregnancy, including the intersection of perinatal incarceration and substance use disorders, and highlight pregnancy and birth disparities that exist for … Read more
If you're ready to learn how to find funding sources and write winning grant proposals, you've come to the right place. Beginning and experienced grant writers from city, county and state agencies as well as healthcare organizations, nonprofits, K-12, colleges and universities are encouraged to attend. You do not need to work in the same profession … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
This is the second in a two-part series focused on the sexual and reproductive health needs of women and others assigned female at birth. We will describe trends in access to contraception, menstrual health, menopause care, and other elements of sexual and reproductive health care during incarceration and criminal legal involvement and highlight reproductive health … Read more